文章名稱引用次數(shù)

• Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended-Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials17
• A Phase Randomized, Placebo-Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major Surgery10
• Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects8
• Phase Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers7
• A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects6
• Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology6
• Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single- and Multiple-Dose Administration in Healthy Japanese Adults5
• Elagolix Pharmacokinetic Profiles in Women With Renal or Hepatic Impairment5
• Phase 1 Single- and Multiple-Ascending-Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG- a First-in-Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers5
• Single- and Multiple-Dose Pharmacokinetics of Once-Daily Formulations of Raltegravir4